Acucela Hires Dr. Lukas Scheibler as Executive Vice President of Translational Medicine

SEATTLE--(BUSINESS WIRE)--Acucela Inc. (TOKYO:4589) (“Acucela” or the “Company”), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, announced today that it has hired Dr. Lukas Scheibler as Executive Vice President of Translational Medicine.

Help employers find you! Check out all the jobs and post your resume.